ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 4.480
-0.040 (-0.88%)
Last updated: Oct 20, 2025, 11:30 AM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €72.83 million as of October 20, 2025. Its market cap has increased by 59.15% in one year.
Market Cap
72.83M
Enterprise Value
74.60M
Revenue
6.23M
Ranking
n/a
PE Ratio
157.19
Stock Price
€4.48
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 72.83M, an increase of 2,803.98%. That is a compound annual growth rate of 14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 72.83M | 83.74% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.11B |
| Sanofi | 105.17B |
| Sartorius Stedim Biotech | 19.71B |
| bioMérieux | 13.02B |
| Eurofins Scientific SE | 11.09B |
| Ipsen | 9.40B |
| ABIVAX Société Anonyme | 5.93B |
| Virbac | 2.79B |